ArticleBreast cancer research : BCR2020

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.

Miguel Quintela-Fandino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.